Corrective Phases R...
Dynavax Technologies Corporation (DVAX: NASDAQ)
$3.56 -0.05 | -1.38%
06/04/12 - 09:45 AM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 31.94M | 22.45M | 36.72M | 28.10M |
| Receivables | 9.53M | 1.00M | 895.00K | 6.41M |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 124.62M | 74.52M | 38.88M | 76.54M |
| Property, Plant & Equipment, Gross | 20.58M | 20.90M | 21.58M | 22.30M |
| Accumulated Depreciation & Depletion | 14.42M | 14.50M | 13.59M | 12.79M |
| Property, Plant & Equipment, Net | 6.16M | 6.40M | 8.00M | 9.51M |
| Intangibles | 0.00 | 299.00K | 1.28M | 2.26M |
| Other Non-Current Assets | 1.01M | 719.00K | 0.00 | 0.00 |
| Total Non-Current Assets | 9.48M | 9.73M | 11.59M | 14.08M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 134.10M | 84.25M | 50.47M | 90.62M |
| Accounts Payable | 2.04M | 2.33M | 1.69M | 905.00K |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 2.57M | 0.00 |
| Total Current Liabilities | 27.22M | 14.70M | 14.48M | 40.85M |
| Long Term Debt | 0.00 | 11.78M | 9.34M | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 7.00M | 5.66M | 20.27M | 33.61M |
| Minority Interest | 0.00 | 0.00 | -4.23M | -5.71M |
| Total Non-Current Liabilities | 7.00M | 17.44M | 29.62M | 36.25M |
| Total Liabilities | 34.22M | 32.14M | 44.09M | 77.10M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 99.88M | 52.11M | 6.38M | 13.52M |
| Common Par | 155.00K | 116.00K | 54.00K | 40.00K |
| Additional Paid In Capital | 466.28M | 369.69M | 266.13M | 262.58M |
| Cumulative Translation Adjustment | -1.01M | -729.00K | -168.00K | -403.00K |
| Retained Earnings | -365.54M | -316.94M | -259.64M | -248.74M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -3.00K | -17.00K | 0.00 | 49.00K |
| Total Capitalization | 99.88M | 63.89M | 15.72M | 13.52M |
| Total Equity | 99.88M | 52.11M | 6.38M | 13.52M |
| Total Liabilities & Stock Equity | 134.10M | 84.25M | 50.47M | 90.62M |
| Total Common Shares Outstanding | 154.63M | 115.61M | 54.28M | 39.92M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 125.10M | 82.46M | 40.35M | 39.82M |
| Diluted Weighted Shares Outstanding | 125.10M | 82.46M | 40.35M | 39.82M |
| Number of Employees | 150 | 128 | 130 | 155 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with DVAX
- Portfolio NameUser Type
- Contributor10 Stocks Boosting Little F...
- UserMy stocks
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Stocks of Top-Performing...
- ContributorStocks At New 52-Week Highs...
- Contributor13 Biotech Stocks Bought an...
- Contributor10 Pharma Stocks Under $3
- Contributor4 Biotech Penny Stocks to Buy
- UserMy Portfolio
- UserStarters
Latest DVAX Headlines from TheStreet
- Dynavax Stock Gaps Down On Today's Open (DVAX) 05.09.12 | 09:05 am
- 10 Stocks Boosting Little Funds to Big Returns (Update2) 03.16.12 | 02:03 pm
- 8 Stocks Under $10 Moving Higher 02.02.12 | 02:02 pm
- 10 Stocks of Top-Performing Funds in 2012 01.20.12 | 10:01 am
- Biotech Calendar: Key Dates for October 10.03.11 | 08:10 am
- Biotech Calendar: Key Dates for September 08.31.11 | 06:08 am
- Dynavax Stock Gaps Down On Today's Open (DVAX) 07.20.11 | 09:07 am
- 10 Pharma Stocks Under $3 06.16.11 | 01:06 pm
- 4 Biotech Penny Stocks to Buy: Navellier 04.13.11 | 11:04 am
- Dynavax, Frontier Financial: Early Volume Plays 04.27.10 | 07:04 am
Press Releases for DVAX
Partner Headlines for DVAX
- Company News for May 10, 2012 - Corporate Summary - Zacks 05.10.12 | 10:05 am
- Buy And Sell Ideas Based On Monday's Big Biotech News Movers - Seeking Alpha 10.11.11 | 08:10 am
- Dynavax Reports Diabetic Subset Data From Modified Intent to Treat Analysis of the HEPLISAV Phase 3 Trial - Benzinga 10.06.11 | 04:10 pm
- 7 Breakout Stocks With Sufficient Cash to Cover Operating Expenses - Seeking Alpha 03.29.11 | 08:03 am
- Data from Dynavax for HBV Candidate - Analyst Blog - Zacks 12.27.10 | 01:12 pm
- Dynavax Announces $30 Million Common Stock Purchase (DVAX) - Benzinga 09.20.10 | 04:09 pm
- UPDATE 1-Dynavax posts Q2 loss, shares fall - Reuters 07.30.10 | 05:07 pm
- UPDATE 1-Dynavax's flu vaccine shows promise, shares rise - Reuters 04.26.10 | 05:04 pm
- Healthcare, Technology Converge: Recent Biotech Deals - SeekingAlpha.com 04.19.10 | 05:04 am
- UPDATE 1-Dynavax hep B vaccine shows promise in kidney disease - Reuters 04.14.10 | 05:04 pm





